| Annual Financials | 2022 | 2023 | 2024 | 2025 | 2026 | TTM |
Revenue  | 45 | 40 | 54 | 63 | 69 | 0 |
| Expenses | 39 | 35 | 45 | 52 | 66 | 0 |
| EBITDA | 6 | 5 | 9 | 12 | 3 | 0 |
| Operating Profit % | 13 % | 11 % | 16 % | 17 % | 5 % | 0 % |
| Depreciation | 1 | 2 | 2 | 3 | 3 | 0 |
| Interest | 1 | 1 | 2 | 2 | 1 | 0 |
| Profit Before Tax | 4 | 3 | 5 | 7 | -0 | 0 |
| Tax | 0 | 1 | 1 | 2 | 0 | 0 |
| Net Profit | 3 | 2 | 4 | 5 | -1 | 0 |
| EPS in ₹ | 2.84 | 1.56 | 3.05 | 3.31 | -0.12 | 0.00 |
Onyx Biotec
Onyx Biotec
43.00
-1.00
(-2.27%)
Market Cap
77.97 Cr
PE Ratio
-366.67
Volume
44,000.00
Day High - Low
44.00 - 42.00
52W High-Low
56.00 - 24.20
Key Fundamentals
Market Cap
77.97 Cr
EPS
-0.12
PE Ratio
-366.67
PB Ratio
1.44
Book Value
30.56
EBITDA
3.40
Dividend Yield
0.00 %
Industry
Healthcare Sector
Pharmaceuticals Return on Equity
8.91
Debt to Equity
0.53
Actual
Company News
View All News
Onyx Biotec Ltd. disclosed no encumbrance on shares for FY26. Promoters confirmed compliance with SEBI regulations on April 07, 2026.
Promoter Sanjay Jain disposed of 1,774,000 equity shares, representing 9.78% of Onyx Biotec, on May 29, 2026. The shares were sold on the NSE for a total value of ₹5,43,55,360.
Managing Director Sanjay Jain and Whole Time Director Lakshya Jain resigned from Onyx Biotec Ltd effective May 27, 2026, citing personal reasons.
View more
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
1,780.10 | #1 4,27,105.62 | 37.30 | #1 58,220.10 | 6.38 | #1 11,565 | 25.80 | 42.78 | |
6,596.50 | 1,75,116.35 | 67.97 | 10,560.00 | 8.73 | 2,520 | 13.44 | 47.99 | |
4,339.90 | 1,46,881.94 | 69.16 | 13,886.20 | 20.34 | 2,138 | -26.91 | 48.37 | |
1,398.70 | 1,12,984.28 | 28.76 | 27,711.70 | -2.46 | 3,783 | -55.32 | 58.01 | |
1,084.60 | 1,09,136.14 | 21.14 | 26,719.70 | 13.65 | 5,242 | 7.82 | 70.26 | |
1,267.50 | 1,05,791.00 | 25.35 | 33,593.30 | -0.44 | 3,998 | -86.05 | 42.70 | |
2,249.80 | 1,02,825.58 | #1 19.30 | 27,487.50 | 19.98 | 5,345 | #1 87.72 | 43.27 | |
2,353.00 | 97,133.03 | 50.52 | 14,277.60 | 12.03 | 1,750 | 31.75 | 48.78 | |
1,463.60 | 85,006.13 | 23.88 | 33,384.70 | 3.21 | 3,376 | 1.99 | 54.11 | |
1,427.20 | 77,048.33 | 84.57 | 6,812.90 | #1 21.03 | 884 | 21.18 | 79.30 |
Growth Rate
Revenue Growth
10.10 %
Net Income Growth
-116.40 %
Cash Flow Change
-6.58 %
ROE
-38.00 %
ROCE
1.02 %
EBITDA Margin (Avg.)
-73.36 %
Yearly Financial Results
Balance Sheet
| Balance Sheet | 2022 | 2023 | 2024 | 2025 | 2026 |
| Total Assets | 37 | 59 | 74 | 91 | 95 |
| Fixed Assets | 17 | 43 | 44 | 41 | 43 |
| Current Assets | 14 | 15 | 30 | 49 | 51 |
| Capital Work in Progress | 4 | 0 | 0 | 0 | 4 |
| Investments | 0 | 0 | 0 | 0 | 14 |
| Other Assets | 16 | 16 | 31 | 50 | 0 |
| Total Equity & Liabilities | 37 | 59 | 74 | 91 | 95 |
| Current Liabilities | 10 | 20 | 23 | 26 | 33 |
| Non Current Liabilities | 10 | 20 | 26 | 10 | 7 |
| Total Equity | 16 | 18 | 25 | 56 | 55 |
| Reserve & Surplus | 11 | 12 | 12 | 38 | 37 |
| Share Capital | 6 | 6 | 13 | 18 | 18 |
Cash Flow
| Cash Flow | 2022 | 2023 | 2024 | 2025 |
| Net Cash Flow | -0 | -4 | 2 | 7 |
| Investing Activities | -6 | -23 | -3 | 1 |
| Operating Activities | 1 | 2 | 2 | 1 |
| Financing Activities | 5 | 16 | 3 | 5 |
Share Holding
| % Holding | Nov 2024 | Mar 2025 | Sept 2025 | Mar 2026 |
| Promoter | 65.10 % | 65.10 % | 65.10 % | 65.10 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 1.07 % |
| DIIs | 0.03 % | 0.00 % | 0.00 % | 2.39 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 18.96 % | 18.97 % | 22.64 % | 23.15 % |
| Others | 15.92 % | 15.94 % | 12.27 % | 8.29 % |
| No of Share Holders | 1,181 | 551 | 640 | 586 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 10 Jan 2025 |  Quarterly Result Announcement | NA | 10 Jan 2025 | 90.15 | 78.95 |
| 28 May 2025 | Quarterly Result Announcement | NA | 28 May 2025 | 49.25 | 49.90 |
| 13 Nov 2025 | Quarterly Result Announcement | NA | 13 Nov 2025 | 39.00 | 42.80 |
| 14 May 2026 | Quarterly Result Announcement | NA | 14 May 2026 | 34.70 | 33.00 |
Technical Indicators
RSI(14)
Neutral 69.82
ATR(14)
Volatile 2.94
STOCH(9,6)
Overbought 82.81
STOCH RSI(14)
Overbought 93.59
MACD(12,26)
Bullish 1.17
ADX(14)
Weak Trend 20.13
UO(9)
Bearish 73.12
ROC(12)
Uptrend And Accelerating 30.18
WillR(14)
Overbought -4.81
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
